Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alcoholism
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. POWELL A, Sumnall H, Smith J, Kuiper R, et al
    Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Systematic review of longitudinal studies.
    PLoS One. 2024;19:e0296043.
    >> Share

  2. DE BEJCZY A, Lido H, Soderpalm B
    A randomized, double-blind, placebo-controlled, multicentre trial on the efficacy of varenicline and bupropion in combination and alone for treatment of alcohol use disorder: Protocol for the COMB study.
    PLoS One. 2024;19:e0296118.
    >> Share

  3. PARADA S, Rubio B, Taschini E, Laqueille X, et al
    Creating a psychosocial intervention combining growth mindset and implementation intentions (GMII) to reduce alcohol consumption: A mixed method approach.
    PLoS One. 2024;19:e0297647.
    >> Share

  4. SUHAG A, Webb TL, Holmes J
    Longitudinal clustering of health behaviours and their association with multimorbidity in older adults in England: A latent class analysis.
    PLoS One. 2024;19:e0297422.
    >> Share

  5. KHALIFA A, Palu R, Perkins AE, Volz A, et al
    Prenatal alcohol exposure alters expression of genes involved in cell adhesion, immune response, and toxin metabolism in adolescent rat hippocampus.
    PLoS One. 2024;19:e0293425.
    >> Share

  6. MCCABE EM, Luk JW, Stangl BL, Schwandt ML, et al
    Exercising healthy behaviors: A latent class analysis of positive coping during the COVID-19 pandemic and associations with alcohol-related and mental health outcomes.
    PLoS One. 2024;19:e0297060.
    >> Share

  7. NAIRZ J, Messner A, Kiechl SJ, Winder B, et al
    Determinants of non-alcoholic fatty liver disease in young people: Maternal, neonatal, and adolescent factors.
    PLoS One. 2024;19:e0298800.
    >> Share

  8. TSUI JI, Rossi SL, Cheng DM, Bendiks S, et al
    Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems.
    PLoS One. 2024;19:e0297948.
    >> Share

  9. ELGUEZABAL RODELO RG, Porchia LM, Torres-Rasgado E, Lopez-Bayghen E, et al
    Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
    PLoS One. 2024;19:e0298662.
    >> Share

  10. NILSSON AH, Schwartz HA, Rosenthal RN, McKay JR, et al
    Language-based EMA assessments help understand problematic alcohol consumption.
    PLoS One. 2024;19:e0298300.
    >> Share

  11. THOMAS S, Schafer J, Kanske P, Trautmann S, et al
    Patterns of social-affective responses to trauma exposure and their relation to psychopathology.
    PLoS One. 2024;19:e0289664.
    >> Share

  12. TUMWEGAMIRE A, Fatch R, Emenyonu NI, Lodi S, et al
    Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
    PLoS One. 2024;19:e0300508.
    >> Share

  13. CAI W, Qiu T, Hu W, Fang T, et al
    Changes in the intestinal microbiota of individuals with non-alcoholic fatty liver disease based on sequencing: An updated systematic review and meta-analysis.
    PLoS One. 2024;19:e0299946.
    >> Share

  14. POPOVA S, Dozet D, Temple V, McFarlane A, et al
    Fetal alcohol spectrum disorder diagnostic clinic capacity in Canadian Provinces and territories.
    PLoS One. 2024;19:e0301615.
    >> Share

  15. FARNIA V, Ahmadi Jouybari T, Salemi S, Moradinazar M, et al
    The prevalence of alcohol consumption and its related factors in adolescents: Findings from Global School-based Student Health Survey.
    PLoS One. 2024;19:e0297225.
    >> Share

  16. SHCHETININA A, Slopen N
    Unmet need for alcohol use disorder treatment in reproductive-age females, with emphasis on pregnant and parenting populations in the United States: Findings from NSDUH 2015-2021.
    PLoS One. 2024;19:e0301810.
    >> Share

  17. CHAVEZ-TAPIA NC, Sanchez-Jimenez BA, Vidana-Perez D, Corrales-Rosas B, et al
    Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
    PLoS One. 2024;19:e0290632.
    >> Share

  18. JOSE R, Wang W, Sherman G, Rosenthal RN, et al
    Tapping into alcohol use during COVID: Drinking correlates among bartenders and servers.
    PLoS One. 2024;19:e0300932.
    >> Share

  19. LIN YH, Zhang ZJ, Zhong JQ, Wang ZY, et al
    Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0302155.
    >> Share

  20. HAVLIK JL, Rhee TG, Rosenheck RA
    Association of mental health related quality of life and other factors with treatment seeking for substance use disorders: A comparison of SUDs rooted in legal, partially legal, and illegal substances.
    PLoS One. 2024;19:e0302544.
    >> Share

    January 2023

  21. Expression of Concern: Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.
    PLoS One. 2023;18:e0279460.
    >> Share


  22. Expression of Concern: Influence of nicotine on choline-deficient, L-amino acid-defined diet-induced non-alcoholic steatohepatitis in rats.
    PLoS One. 2023;18:e0279807.
    >> Share

  23. KASZTELAN-SZCZERBINSKA B, Zygo B, Rycyk-Bojarzynska A, Surdacka A, et al
    Blood concentrations of mediators released from activated neutrophils are related to the severity of alcohol-induced liver damage.
    PLoS One. 2023;18:e0280068.
    >> Share

  24. CHUI Z, Leightley D, Jones M, Landau S, et al
    Mental health problems and admissions to hospital for accidents and injuries in the UK military: A data linkage study.
    PLoS One. 2023;18:e0280938.
    >> Share

  25. DAVITKOV P, Hoffman K, Falck-Ytter Y, Wilson B, et al
    Increasing liver stiffness is associated with higher incidence of hepatocellular carcinoma in hepatitis C infection and non-alcoholic fatty liver disease-A population-based study.
    PLoS One. 2023;18:e0280647.
    >> Share

  26. GAWRIEH S, Corey KE, Lake JE, Samala N, et al
    Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus.
    PLoS One. 2023;18:e0279685.
    >> Share

  27. JONES L, Owens L, Thompson A, Gilmore I, et al
    Informing the development of diagnostic criteria for differential diagnosis of alcohol-related cognitive impairment (ARCI) among heavy drinkers: A systematic scoping review.
    PLoS One. 2023;18:e0280749.
    >> Share

  28. SANT ANNA FM, Araujo-Pereira M, Schmaltz CAS, Arriaga MB, et al
    Impact of adverse drug reactions on the outcomes of tuberculosis treatment.
    PLoS One. 2023;18:e0269765.
    >> Share

  29. BIANCHI LL, da Silva C, Lazaretti LR, Franca MTA, et al
    What factors matter in the amount of alcohol consumed? An analysis among Brazilian adolescents.
    PLoS One. 2023;18:e0281065.
    >> Share

  30. BUTLER JL, Gordon-Larsen P, Steffen LM, Shikany JM, et al
    Associations of 5-year changes in alcoholic beverage intake with 5-year changes in waist circumference and BMI in the Coronary Artery Risk Development in Young Adults (CARDIA) study.
    PLoS One. 2023;18:e0281722.
    >> Share

  31. JEONG W
    Comparison of alcohol consumption and tobacco use among Korean adolescents before and during the COVID-19 pandemic.
    PLoS One. 2023;18:e0283462.
    >> Share

  32. YOKOYAMA A, Kimura M, Yoshimura A, Matsushita S, et al
    Nonsmoking after simultaneous alcohol abstinence and smoking cessation program was associated with better drinking status outcome in Japanese alcohol-dependent men: A prospective follow-up study.
    PLoS One. 2023;18:e0282992.
    >> Share

  33. MATULYTE E, Davidaviciene E, Kancauskiene Z, Diktanas S, et al
    The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis.
    PLoS One. 2023;18:e0282046.
    >> Share

  34. SKRZYNSKI CJ, Creswell KG
    Solitary-specific drinking to cope motives explain unique variance in solitary drinking behavior but not alcohol problems compared to general drinking to cope motives.
    PLoS One. 2023;18:e0282506.
    >> Share

  35. MONK RL, Qureshi AW, Richardson GB, Heim D, et al
    UK alcohol consumption during the COVID-19 pandemic: The role of drinking motives, employment and subjective mental health.
    PLoS One. 2023;18:e0283233.
    >> Share

  36. GILBERT PA, Soweid L, Holdefer PJ, Kersten S, et al
    Strategies to maintain recovery from alcohol problems during the COVID-19 pandemic: Insights from a mixed-methods national survey of adults in the United States.
    PLoS One. 2023;18:e0284435.
    >> Share

  37. FUENTES-BEALS C, Olivares-Costa M, Andres ME, Haeger PA, et al
    Bioinformatic analysis predicts that ethanol exposure during early development causes alternative splicing alterations of genes involved in RNA post-transcriptional regulation.
    PLoS One. 2023;18:e0284357.
    >> Share

  38. LADI-AKINYEMI T', Okpue AP, Onigbinde OA, Okafor IP, et al
    Depression and suicidal ideation among undergraduates in state tertiary institutions in Lagos Nigeria.
    PLoS One. 2023;18:e0284955.
    >> Share

  39. GENTRY AE, Alexander JC, Ahangari M, Peterson RE, et al
    Case-only exome variation analysis of severe alcohol dependence using a multivariate hierarchical gene clustering approach.
    PLoS One. 2023;18:e0283985.
    >> Share

  40. BUYCO DG, Dempsey JL, Scorletti E, Jeon S, et al
    Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism.
    PLoS One. 2023;18:e0281954.
    >> Share

  41. KANG SJ, Pei CZ, Lee DH, Ha JE, et al
    A pilot randomized clinical trial of biomedical link with mental health in art therapy intervention programs for alcohol use disorder: Changes in NK cells, addiction biomarkers, electroencephalography, and MMPI-2 profiles.
    PLoS One. 2023;18:e0284344.
    >> Share

  42. JACKSON SE, Cox S, Shahab L, Brown J, et al
    Impact of the cost-of-living crisis on the nature of attempts to stop smoking and to reduce alcohol consumption in Great Britain: A representative population survey, 2021-2022.
    PLoS One. 2023;18:e0286183.
    >> Share

  43. MITROVIC N, Sabanovic M, Vujovic A, Jovanovic J, et al
    Influence of chronic liver diseases on the course and outcome of COVID-19.
    PLoS One. 2023;18:e0288350.
    >> Share

  44. BRADSHAW D, Abramowicz I, Bremner S, Verma S, et al
    Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease.
    PLoS One. 2023;18:e0288598.
    >> Share

  45. KRUGER K, Oedingen C, Kautz A, Langenbacher D, et al
    Lifestyle interventions for patients with non-alcoholic steato-hepatitis-Design, rationale and protocol of the study "target group-specific optimisation of lifestyle interventions for behavior change in non-alcoholic steato-hepatitis (OPTI-NASH)".
    PLoS One. 2023;18:e0288905.
    >> Share

  46. EVERETT RA, Lewis AL, Kuerbis A, Peace A, et al
    Data driven mixed effects modeling of the dual process framework of addiction among individuals with alcohol use disorder.
    PLoS One. 2023;18:e0265168.
    >> Share

  47. CHANDRA R, Srivastava S, Singh A, Mukherjee S, et al
    Locating perpetrators of violence against women in India: An analysis of married men's characteristics associated with intimate partner violence.
    PLoS One. 2023;18:e0289596.
    >> Share

  48. STATON CA, Friedman K, Phillips AJ, Minnig MC, et al
    Feasibility of a pragmatic randomized adaptive clinical trial to evaluate a brief negotiational interview for harmful and hazardous alcohol use in Moshi, Tanzania.
    PLoS One. 2023;18:e0288458.
    >> Share

  49. PESTI-ASBOTH G, Szilagyi E, Birone Molnar P, Olah J, et al
    Monitoring physiological processes of fast-growing broilers during the whole life cycle: Changes of redox-homeostasis effected to trassulfuration pathway predicting the development of non-alcoholic fatty liver disease.
    PLoS One. 2023;18:e0290310.
    >> Share

  50. BLAKE H, Yildirim M, Premakumar V, Morris L, et al
    Attitudes and current practice in alcohol screening, brief intervention, and referral for treatment among staff working in urgent and emergency settings: An open, cross-sectional international survey.
    PLoS One. 2023;18:e0291573.
    >> Share

  51. AKWA LG, Smith L, Twiddy M, Abt G, et al
    Associations between physical activity, sedentary behaviour, and alcohol consumption among UK adults: Findings from the Health Behaviours during the COVID-19 pandemic (HEBECO) study.
    PLoS One. 2023;18:e0287199.
    >> Share

  52. HUANG Q, Guo J, Zhao H, Zheng Y, et al
    The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.
    PLoS One. 2023;18:e0292881.
    >> Share

  53. MONTGOMERY C, Saini P, Schoetensack C, McCarthy M, et al
    Improving access to treatment for alcohol dependence in primary care: A qualitative investigation of factors that facilitate and impede treatment access and completion.
    PLoS One. 2023;18:e0292220.
    >> Share

  54. CHACON C, Arteaga I, Martinez-Escude A, Ruiz Rojano I, et al
    Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol.
    PLoS One. 2023;18:e0286586.
    >> Share

  55. GUIMARAES RA, de Morais Neto OL, Dos Santos TMB, Mandacaru PMP, et al
    Impact of the program life in traffic and new zero-tolerance drinking and driving law on the prevalence of driving after alcohol abuse in Brazilian capitals: An interrupted time series analysis.
    PLoS One. 2023;18:e0288288.
    >> Share

  56. VISSOCI JRN, Friedman K, Caruzzo NM, de Oliveira LP, et al
    Clinical evaluation of the alcohol use disorders identification test (AUDIT) in Moshi, Tanzania.
    PLoS One. 2023;18:e0287835.
    >> Share

  57. WEN W, Guo C, Chen Z, Yang D, et al
    Regular exercise attenuates alcoholic myopathy in zebrafish by modulating mitochondrial homeostasis.
    PLoS One. 2023;18:e0294700.
    >> Share

  58. ROUSSON V, Trachsel B, Iglesias K, Baggio S, et al
    Evaluating the cost of simplicity in score building: An example from alcohol research.
    PLoS One. 2023;18:e0294671.
    >> Share

  59. PURUSHOTHAMA C, Crape BL, Stolyarov V, Jaxybayeva A, et al
    Preloaded combination nicotine replacement therapy for smoking cessation in Kazakhstan: A randomized controlled trial study protocol.
    PLoS One. 2023;18:e0292490.
    >> Share

  60. ZHANG B, Zhang R, Deng H, Cui P, et al
    Research protocol of the efficacy of probiotics for the treatment of alcohol use disorder among adult males: A comparison with placebo and acceptance and commitment therapy in a randomized controlled trial.
    PLoS One. 2023;18:e0294768.
    >> Share

  61. SABRI B, Budhathoki C, McFall AM, Mehta SH, et al
    Cumulative violence exposures among men who have sex with men living with HIV in India: Psychosocial correlates of HIV care continuum outcomes.
    PLoS One. 2023;18:e0295225.
    >> Share

  62. YOUSSEF L, Salameh P, Sacre H, Akel M, et al
    Association between alexithymia, emotional intelligence, smoking addiction, and alcohol use disorder among a sample of Lebanese adults.
    PLoS One. 2023;18:e0295114.
    >> Share

  63. MOUNIKA N, Yadav A, Kamboj P, Banerjee SK, et al
    Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2023;18:e0295839.
    >> Share

  64. JIA X, Zhang X, Zhou T, Sun D, et al
    Cyp3A4 *1G polymorphism is associated with alcohol drinking: A 5-year retrospective single centered population-based study in China.
    PLoS One. 2023;18:e0295184.
    >> Share

  65. PELOSO A, Lacotte S, Gex Q, Slits F, et al
    Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models.
    PLoS One. 2023;18:e0296265.
    >> Share

    January 2022
  66. RADFORD-SMITH DE, Patel PJ, Irvine KM, Russell A, et al
    Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism.
    PLoS One. 2022;17:e0261555.
    >> Share

  67. S HASHEMI N, Skogen JC, Sevic A, Thorrisen MM, et al
    A systematic review and meta-analysis uncovering the relationship between alcohol consumption and sickness absence. When type of design, data, and sickness absence make a difference.
    PLoS One. 2022;17:e0262458.
    >> Share

  68. POWELL LM, Leider J
    Impact of the Seattle Sweetened Beverage Tax on substitution to alcoholic beverages.
    PLoS One. 2022;17:e0262578.
    >> Share

  69. JOLEX A, Kaluwa B
    Crowding Out Effects of Alcohol Consumption Expenditure on Household Resource Allocation in Malawi.
    PLoS One. 2022;17:e0263330.
    >> Share

  70. TOVMASYAN A, Monk RL, Heim D
    Towards an affect intensity regulation hypothesis: Systematic review and meta-analyses of the relationship between affective states and alcohol consumption.
    PLoS One. 2022;17:e0262670.
    >> Share

  71. ASADULLAH M, Shivashankar R, Shalimar, Kandasamy D, et al
    Rural-Urban differentials in prevalence, spectrum and determinants of Non-alcoholic Fatty Liver Disease in North Indian population.
    PLoS One. 2022;17:e0263768.
    >> Share

  72. THOMAS KL, Root CL, Peterson JM
    Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female mice.
    PLoS One. 2022;17:e0258557.
    >> Share

  73. FERNANDEZ T, Vinuela M, Vidal C, Barrera F, et al
    Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0263931.
    >> Share

  74. MORISHITA A, Tadokoro T, Fujihara S, Iwama H, et al
    Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
    PLoS One. 2022;17:e0261310.
    >> Share

  75. CHOSY EJ, Edland S, Launer L, White LR, et al
    Midlife alcohol consumption and later life cognitive impairment: Light drinking is not protective and APOE genotype does not change this relationship.
    PLoS One. 2022;17:e0264575.
    >> Share

  76. SANTOS MGR, Sanchez ZM, Hughes K, Gee I, et al
    Pre-drinking, alcohol consumption and related harms amongst Brazilian and British university students.
    PLoS One. 2022;17:e0264842.
    >> Share

  77. HAMADA S, Takata T, Yamada K, Yamamoto M, et al
    Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
    PLoS One. 2022;17:e0265461.
    >> Share

  78. KIMER N, Meldgaard M, Hamberg O, Kronborg TM, et al
    The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial.
    PLoS One. 2022;17:e0264278.
    >> Share

  79. DONOGHUE K, Hermann L, Brobbin E, Drummond C, et al
    The rates and measurement of adherence to acamprosate in randomised controlled clinical trials: A systematic review.
    PLoS One. 2022;17:e0263350.
    >> Share

  80. ANENI EC, Saeed GJ, Bittencourt MS, Cainzos-Achirica M, et al
    Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
    PLoS One. 2022;17:e0266505.
    >> Share

  81. CAROL M, Perez-Guasch M, Sola E, Cervera M, et al
    Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
    PLoS One. 2022;17:e0265153.
    >> Share

  82. SALMAN M, Kamel MA, El-Nabi SEH, Ismail AHA, et al
    The regulation of HBP1, SIRT1, and SREBP-1c genes and the related microRNAs in non-alcoholic fatty liver rats: The association with the folic acid anti-steatosis.
    PLoS One. 2022;17:e0265455.
    >> Share

  83. SARMADI N, Poustchi H, Ali Yari F, Radmard AR, et al
    Anti-inflammatory function of apolipoprotein B-depleted plasma is impaired in non-alcoholic fatty liver disease.
    PLoS One. 2022;17:e0266227.
    >> Share

  84. KUMAR RG, Esterov D, Adams RS, Corrigan JD, et al
    Changes in alcohol use and mood during the COVID-19 pandemic among individuals with traumatic brain injury: A difference-in-difference study.
    PLoS One. 2022;17:e0266422.
    >> Share

  85. KOVACS I, Gal BI, Horvath Z, Demeter I, et al
    Externalizing personality characteristics define clinically relevant subgroups of alcohol use disorder.
    PLoS One. 2022;17:e0265577.
    >> Share

  86. SUBHANI M, Talat U, Knight H, Morling JR, et al
    Characteristics of alcohol recovery narratives: Systematic review and narrative synthesis.
    PLoS One. 2022;17:e0268034.
    >> Share

  87. ACHARYA B, Dhakal C
    Risky health behaviors during the COVID-19 pandemic: Evidence from the expenditures on alcohol, non-alcoholic beverages, and tobacco products.
    PLoS One. 2022;17:e0268068.
    >> Share

  88. TAKATS A, Berke G, Gede N, Nemeth BC, et al
    Risk of chronic pancreatitis in carriers of loss-of-function CTRC variants: A meta-analysis.
    PLoS One. 2022;17:e0268859.
    >> Share

  89. RIVERA AC, LeardMann CA, Rull RP, Cooper A, et al
    Combat exposure and behavioral health in U.S. Army Special Forces.
    PLoS One. 2022;17:e0270515.
    >> Share

  90. PARCESEPE AM, Filiatreau LM, Ebasone PV, Dzudie A, et al
    Psychiatric comorbidity and psychosocial stressors among people initiating HIV care in Cameroon.
    PLoS One. 2022;17:e0270042.
    >> Share

  91. KIM N, Roh JH, Lee H, Kim D, et al
    The impact of non-alcoholic fatty liver disease on sleep apnea in healthy adults: A nationwide study of Korea.
    PLoS One. 2022;17:e0271021.
    >> Share

  92. ZETTERSTROM A, Dahlberg G, Lundqvist S, Hamalainen MD, et al
    Processing incomplete questionnaire data into continuous digital biomarkers for addiction monitoring.
    PLoS One. 2022;17:e0271465.
    >> Share

  93. JAYATHILAKA R, Athukorala O, Ishara S, Silva D, et al
    Alcohol brings burdens: A global and continent wise study on alcohol consumption and global burden of diseases.
    PLoS One. 2022;17:e0270998.
    >> Share

  94. DIESE EL, Raines-Milenkov A, Felini M, Akpan I, et al
    Alcohol use among Congolese Babembe male refugees in Tarrant County: A qualitative study.
    PLoS One. 2022;17:e0272293.
    >> Share

  95. DE OLIVEIRA SANTOS EG, Vedana KGG, Barbosa IR
    Prevalence and factors associated with suicidal ideation among farmers.
    PLoS One. 2022;17:e0273625.
    >> Share

  96. HEREDIA JE, Sorenson C, Flanagan S, Nunez V, et al
    IL-23 signaling is not an important driver of liver inflammation and fibrosis in murine non-alcoholic steatohepatitis models.
    PLoS One. 2022;17:e0274582.
    >> Share

  97. OKOYO C, Njambi E, Were V, Araka S, et al
    Prevalence, types, patterns and risk factors associated with drugs and substances of use and abuse: A cross-sectional study of selected counties in Kenya.
    PLoS One. 2022;17:e0273470.
    >> Share

  98. ACHESON LS, Ezard N, Lintzeris N, Dunlop A, et al
    Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.
    PLoS One. 2022;17:e0275371.
    >> Share

  99. POWELL A, Sumnall H, Smith J, Kuiper R, et al
    Recovery of neuropsychological function following abstinence from alcohol in adults diagnosed with an alcohol use disorder: Protocol for a systematic review of longitudinal studies.
    PLoS One. 2022;17:e0274752.
    >> Share

  100. SUNG C, Chung CH, Lin FH, Chien WC, et al
    Risk of cardiovascular disease in patients with alcohol use disorder: A population-based retrospective cohort study.
    PLoS One. 2022;17:e0276690.
    >> Share

  101. DE FREITAS MG, Silva END
    Direct and indirect costs attributed to alcohol consumption in Brazil, 2010 to 2018.
    PLoS One. 2022;17:e0270115.
    >> Share

  102. GROBBEE EJ, de Jong VD, Schrieks IC, Tushuizen ME, et al
    Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-alpha/gamma agonist aleglitazar.
    PLoS One. 2022;17:e0277706.
    >> Share

  103. MICHELSEN ME, Gronkjaer M, Mortensen EL, Wimmelmann CL, et al
    Social, psychological and health characteristics associated with stability and change in adult alcohol consumption.
    PLoS One. 2022;17:e0277511.
    >> Share

  104. KIYOAKI I, Sumida Y, Nakade Y, Okumura A, et al
    Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis.
    PLoS One. 2022;17:e0277380.
    >> Share

  105. NEUFELD M, Ferreira-Borges C, Bunova A, Gornyi B, et al
    Capturing Russian drinking patterns with the Alcohol Use Disorders Identification Test: An exploratory interview study in primary healthcare and narcology centers in Moscow.
    PLoS One. 2022;17:e0274166.
    >> Share

  106. SIMPSON TL, Kaysen DL, Fleming CB, Rhew IC, et al
    Cognitive Processing Therapy or Relapse Prevention for comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A randomized clinical trial.
    PLoS One. 2022;17:e0276111.
    >> Share

  107. DUNGUBAT E, Kusano H, Mori I, Tawara H, et al
    Age-dependent sex difference of non-alcoholic fatty liver disease in TSOD and db/db mice.
    PLoS One. 2022;17:e0278580.
    >> Share

  108. ABOAGYE RG, Ahinkorah BO, Tengan CL, Salifu I, et al
    Partner alcohol consumption and intimate partner violence against women in sexual unions in sub-Saharan Africa.
    PLoS One. 2022;17:e0278196.
    >> Share

  109. KASSEW T, Liyew B, Tarekegn GE, Wondie M, et al
    Spatial distribution and determinants of alcohol consumption among pregnant women in Ethiopia: Spatial and multilevel analysis.
    PLoS One. 2022;17:e0279405.
    >> Share

  110. SHANGANI S, van den Berg JJ, Dyer TV, Mayer KH, et al
    Childhood sexual abuse, alcohol and drug use problems among Black sexual minority men in six US Cities: Findings from the HPTN 061 study.
    PLoS One. 2022;17:e0279238.
    >> Share

    January 2021
  111. PEDRONI C, Dujeu M, Lebacq T, Desnouck V, et al
    Alcohol consumption in early adolescence: Associations with sociodemographic and psychosocial factors according to gender.
    PLoS One. 2021;16:e0245597.
    >> Share

  112. ESTRADA-MARTINEZ S, Perez-Alamos AR, Ibarra-Segovia M, Beristain-Garcia I, et al
    Seroepidemiology of Toxoplasma gondii infection in people with alcohol consumption in Durango, Mexico.
    PLoS One. 2021;16:e0245701.
    >> Share

  113. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    >> Share


  114. Correction: Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2021;16:e0247690.
    >> Share

  115. HENNEIN R, Mew EJ, Lowe SR
    Socio-ecological predictors of mental health outcomes among healthcare workers during the COVID-19 pandemic in the United States.
    PLoS One. 2021;16:e0246602.
    >> Share

  116. DARLING KEA, Locatelli I, Benghalem N, Nadin I, et al
    Alcohol consumption and neurocognitive deficits in people with well-treated HIV in Switzerland.
    PLoS One. 2021;16:e0246579.
    >> Share

  117. SENGUPTA M, Abuirqeba S, Kameric A, Cecile-Valfort A, et al
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
    PLoS One. 2021;16:e0249316.
    >> Share

  118. ARIYA M, Koohpayeh F, Ghaemi A, Osati S, et al
    Assessment of the association between body composition and risk of non-alcoholic fatty liver.
    PLoS One. 2021;16:e0249223.
    >> Share

  119. KURODA H, Fujiwara Y, Abe T, Nagasawa T, et al
    Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis.
    PLoS One. 2021;16:e0249493.
    >> Share

  120. D'AMBROSIO R, Campi I, Maggioni M, Perbellini R, et al
    The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2021;16:e0249614.
    >> Share

  121. BAE CR, Zhang H, Kwon YG
    Correction: The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2021;16:e0249747.
    >> Share

  122. KOUTOUKIDIS DA, Morris E, Henry JA, Shammoon Y, et al
    What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250385.
    >> Share

  123. TAHA MM, Aneis YM, Mohamady HM, S A A, et al
    Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    PLoS One. 2021;16:e0250337.
    >> Share

  124. CONGLY SE, Shaheen AA, Swain MG
    Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting.
    PLoS One. 2021;16:e0251741.
    >> Share

  125. YEN HH, Su PY, Huang SP, Wu L, et al
    Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
    PLoS One. 2021;16:e0252286.
    >> Share

  126. KIM JY, Park YM, Lee GN, Song HC, et al
    Association between toothbrushing and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0243686.
    >> Share

  127. DAYTON KA, Bril F, Barb D, Lai J, et al
    Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
    PLoS One. 2021;16:e0251449.
    >> Share

  128. RENNERT-MAY E, Leal J, Thanh NX, Lang E, et al
    The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study.
    PLoS One. 2021;16:e0252441.
    >> Share

  129. SUKAHRI S, Mohamed Shah FZ, Ismail AI, Koshy M, et al
    Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0253298.
    >> Share

  130. MORAN MW, Ramirez EP, Zook JD, Saarinen AM, et al
    Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0249164.
    >> Share

  131. PRO G, Gilbert PA, Baldwin JA, Brown CC, et al
    Multilevel modeling of county-level excessive alcohol use, rurality, and COVID-19 case fatality rates in the US.
    PLoS One. 2021;16:e0253466.
    >> Share

  132. YOKOYAMA A, Yokoyama T, Kimura M, Matsushita S, et al
    Combinations of alcohol-induced flushing with genetic polymorphisms of alcohol and aldehyde dehydrogenases and the risk of alcohol dependence in Japanese men and women.
    PLoS One. 2021;16:e0255276.
    >> Share

  133. LEE Y, Mun E, Park S, Lee W, et al
    Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study.
    PLoS One. 2021;16:e0255118.
    >> Share

  134. ERIKSEN LL, Nielsen MA, Laursen TL, Deleuran B, et al
    Early loss of T lymphocyte 4-1BB receptor expression is associated with higher short-term mortality in alcoholic hepatitis.
    PLoS One. 2021;16:e0255574.
    >> Share

  135. MANTHEY J, Solovei A, Anderson P, Carr S, et al
    Can alcohol consumption in Germany be reduced by alcohol screening, brief intervention and referral to treatment in primary health care? Results of a simulation study.
    PLoS One. 2021;16:e0255843.
    >> Share

  136. MINICOZZI MR, Axlid EG, von Hippel FA, Espinoza J, et al
    Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.
    PLoS One. 2021;16:e0254500.
    >> Share

  137. DANTAS DMM, Cahu TB, Oliveira CYB, Abadie-Guedes R, et al
    Chlorella vulgaris functional alcoholic beverage: Effect on propagation of cortical spreading depression and functional properties.
    PLoS One. 2021;16:e0255996.
    >> Share

  138. GAUME J, Grazioli VS, Paroz S, Fortini C, et al
    Developing a brief motivational intervention for young adults admitted with alcohol intoxication in the emergency department - Results from an iterative qualitative design.
    PLoS One. 2021;16:e0246652.
    >> Share

  139. O'DONNELL A, Schulte B, Manthey J, Schmidt CS, et al
    Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America.
    PLoS One. 2021;16:e0255594.
    >> Share

  140. VAN DEN TOREN SJ, van Grieken A, Raat H
    Associations of socio-demographic characteristics, well-being, school absenteeism, and substance use with recreational nitrous oxide use among adolescents: A cross-sectional study.
    PLoS One. 2021;16:e0247230.
    >> Share

  141. LI M, Hu M, Yue Z, Zhang Y, et al
    The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
    PLoS One. 2021;16:e0257391.
    >> Share

  142. KAPS L, Ahlbrand CJ, Gadban R, Nagel M, et al
    Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
    PLoS One. 2021;16:e0249342.
    >> Share

  143. WANG IJ, Bae BK, Cho YM, Cho SJ, et al
    Effect of acute alcohol intoxication on mortality, coagulation, and fibrinolysis in trauma patients.
    PLoS One. 2021;16:e0248810.
    >> Share

  144. HANNA CHAIM C, Santana GL, de Vries Albertin P, Silveira CM, et al
    Alcohol use patterns and disorders among individuals with personality disorders in the Sao Paulo Metropolitan Area.
    PLoS One. 2021;16:e0248403.
    >> Share

  145. JACKSON J, Donaldson DI, Dering B
    The morning after the night before: Alcohol-induced blackouts impair next day recall in sober young adults.
    PLoS One. 2021;16:e0250827.
    >> Share

  146. KNIGHT JK, Salali GD, Sikka G, Derkx I, et al
    Quantifying patterns of alcohol consumption and its effects on health and wellbeing among BaYaka hunter-gatherers: A mixed-methods cross-sectional study.
    PLoS One. 2021;16:e0258384.
    >> Share

  147. OSCAR-BERMAN M, Ruiz SM, Marinkovic K, Valmas MM, et al
    Brain responsivity to emotional faces differs in men and women with and without a history of alcohol use disorder.
    PLoS One. 2021;16:e0248831.
    >> Share


  148. Retraction: Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
    PLoS One. 2021;16:e0259219.
    >> Share

  149. KASHYAP GC, Govind B, Srivastava S, R V, et al
    A true face of Indian married couples: Effect of age and education on control over own sexuality and sexual violence.
    PLoS One. 2021;16:e0254005.
    >> Share

  150. HEITMANN J, van Hemel-Ruiter ME, Huisman M, Ostafin BD, et al
    Effectiveness of attentional bias modification training as add-on to regular treatment in alcohol and cannabis use disorder: A multicenter randomized control trial.
    PLoS One. 2021;16:e0252494.
    >> Share

  151. CHARTIER KG, Guidry JPD, Lee CA, Buckley TD, et al
    At home and online during the early months of the COVID-19 pandemic and the relationship to alcohol consumption in a national sample of U.S. adults.
    PLoS One. 2021;16:e0259947.
    >> Share

  152. HOLMES HM, Jove AG, Tan MC, El-Serag HB, et al
    Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population.
    PLoS One. 2021;16:e0260019.
    >> Share

  153. HOWLETT N, Garcia-Iglesias J, Breslin G, Bartington S, et al
    Remote delivery of alcohol and/or substance misuse interventions for adults: A systematic review protocol.
    PLoS One. 2021;16:e0259525.
    >> Share

  154. FILLMORE N, Bell S, Shen C, Nguyen V, et al
    Disulfiram use is associated with lower risk of COVID-19: A retrospective cohort study.
    PLoS One. 2021;16:e0259061.
    >> Share

  155. LEGAS G, Asnakew S, Belete A, Beyene GM, et al
    Magnitude and correlates of alcohol use disorder in south Gondar zone, northwest Ethiopia: A community based cross-sectional study.
    PLoS One. 2021;16:e0257804.
    >> Share

  156. MINNERLY C, Shokry IM, To W, Callanan JJ, et al
    Characteristic changes in EEG spectral powers of patients with opioid-use disorder as compared with those with methamphetamine- and alcohol-use disorders.
    PLoS One. 2021;16:e0248794.
    >> Share

  157. AGUERREBERE M, Frias SM, Smith Fawzi MC, Lopez R, et al
    Intimate partner violence types and symptoms of common mental disorders in a rural community of Chiapas, Mexico: Implications for global mental-health practice.
    PLoS One. 2021;16:e0256850.
    >> Share

  158. GUTEMA H, Debela Y, Walle B, Reba K, et al
    Predicting binge drinking among university students: Application of integrated behavioral model.
    PLoS One. 2021;16:e0254185.
    >> Share

  159. GOYALE A, Jain A, Smith C, Papatheodoridi M, et al
    Assessment of non-alcoholic fatty liver disease (NAFLD) severity with novel serum-based markers: A pilot study.
    PLoS One. 2021;16:e0260313.
    >> Share

  160. JANG DK, Ahn DW, Lee KL, Kim BG, et al
    Impacts of body composition parameters and liver cirrhosis on the severity of alcoholic acute pancreatitis.
    PLoS One. 2021;16:e0260309.
    >> Share

  161. KONRAD G, Leong C, Bolton JM, Prior HJ, et al
    Use of pharmacotherapy for alcohol use disorder in Manitoba, Canada: A whole-population cohort study.
    PLoS One. 2021;16:e0257025.
    >> Share

  162. ALVES RM, Santos EGO, Barbosa IR
    Abuse of alcohol among farmers: Prevalence and associated factors.
    PLoS One. 2021;16:e0254904.
    >> Share

  163. CORDOBA E, Garofalo R, Kuhns LM, Pearson C, et al
    Risk-taking behaviors in adolescent men who have sex with men (MSM): An association between homophobic victimization and alcohol consumption.
    PLoS One. 2021;16:e0260083.
    >> Share

  164. ESKRIDGE W, Vierling JM, Gosbee W, Wan GA, et al
    Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE).
    PLoS One. 2021;16:e0260320.
    >> Share

  165. PARK SJ, Lee SJ, Kim H, Kim JK, et al
    Machine learning prediction of dropping out of outpatients with alcohol use disorders.
    PLoS One. 2021;16:e0255626.
    >> Share

  166. VIGOUROUX A, Garret C, Lascarrou JB, Martin M, et al
    Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors.
    PLoS One. 2021;16:e0261443.
    >> Share

  167. TEVIK K, Bergh S, Selbaek G, Johannessen A, et al
    A systematic review of self-report measures used in epidemiological studies to assess alcohol consumption among older adults.
    PLoS One. 2021;16:e0261292.
    >> Share

  168. MCCRABB S, Mooney K, Wolfenden L, Gonzalez S, et al
    "He who pays the piper calls the tune": Researcher experiences of funder suppression of health behaviour intervention trial findings.
    PLoS One. 2021;16:e0255704.
    >> Share

  169. PERALES JC, Maldonado A, Lopez-Quirantes EM, Lopez-Torrecillas F, et al
    Association patterns of cannabis abuse and dependence with risk of problematic non-substance-related dysregulated and addictive behaviors.
    PLoS One. 2021;16:e0255872.
    >> Share

  170. CHEN Y, Hinton C, VanderWeele TJ
    School types in adolescence and subsequent health and well-being in young adulthood: An outcome-wide analysis.
    PLoS One. 2021;16:e0258723.
    >> Share

  171. SINGINI MG, Sitas F, Bradshaw D, Chen WC, et al
    Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa.
    PLoS One. 2021;16:e0260319.
    >> Share

  172. AKOMBI-INYANG B, Ghimire PR, Archibong E, Woolley E, et al
    Association between intimate partner violence and male alcohol use and the receipt of perinatal care: Evidence from Nepal demographic and health survey 2011-2016.
    PLoS One. 2021;16:e0259980.
    >> Share

  173. RIBEIRO RM, Havik PJ, Craveiro I
    The circuits of healthcare: Understanding healthcare seeking behaviour-A qualitative study with tuberculosis patients in Lisbon, Portugal.
    PLoS One. 2021;16:e0261688.
    >> Share

  174. RODRIGUES R, Lopez-Caneda E, Almeida-Antunes N, Sampaio A, et al
    Portuguese validation of the Alcohol Craving Questionnaire-Short Form-Revised.
    PLoS One. 2021;16:e0251733.
    >> Share

    January 2020
  175. SAWYER KS, Adra N, Salz DM, Kemppainen MI, et al
    Hippocampal subfield volumes in abstinent men and women with a history of alcohol use disorder.
    PLoS One. 2020;15:e0236641.
    >> Share

  176. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
    Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
    PLoS One. 2020;15:e0240867.
    >> Share

  177. CHEN F, Xiao M, Chen C, Chen C, et al
    Discrimination of alcohol dependence based on the convolutional neural network.
    PLoS One. 2020;15:e0241268.
    >> Share

  178. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
    Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    PLoS One. 2020;15:e0241357.
    >> Share

  179. HENNEIN R, Lowe S
    A hybrid inductive-abductive analysis of health workers' experiences and wellbeing during the COVID-19 pandemic in the United States.
    PLoS One. 2020;15:e0240646.
    >> Share

  180. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
    Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
    PLoS One. 2020;15:e0242582.
    >> Share

  181. ADRAWA N, Alege JB, Izudi J
    Alcohol consumption increases non-adherence to ART among people living with HIV enrolled to the community-based care model in rural northern Uganda.
    PLoS One. 2020;15:e0242801.
    >> Share

  182. BAE CR, Zhang H, Kwon YG
    The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2020;15:e0243497.
    >> Share

  183. VIANA PVS, Paiva NS, Villela DAM, Bastos LS, et al
    Factors associated with death in patients with tuberculosis in Brazil: Competing risks analysis.
    PLoS One. 2020;15:e0240090.
    >> Share

  184. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
    Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2020;15:e0240338.
    >> Share

  185. VORNHOLT E, Drake J, Mamdani M, McMichael G, et al
    Network preservation reveals shared and unique biological processes associated with chronic alcohol abuse in NAc and PFC.
    PLoS One. 2020;15:e0243857.
    >> Share

  186. RADCLIFFE RA, Dowell R, Odell AT, Richmond PA, et al
    Systems genetics analysis of the LXS recombinant inbred mouse strains:Genetic and molecular insights into acute ethanol tolerance.
    PLoS One. 2020;15:e0240253.
    >> Share

  187. FRANK K, Abeynaike S, Nikzad R, Patel RR, et al
    Alcohol dependence promotes systemic IFN-gamma and IL-17 responses in mice.
    PLoS One. 2020;15:e0239246.
    >> Share

  188. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    >> Share

  189. KILIAN C, Manthey J, Moskalewicz J, Scafato E, et al
    Comparing subjective intoxication with risky single-occasion drinking in a European sample.
    PLoS One. 2020;15:e0241433.
    >> Share

  190. LONG JE, Richardson BA, Wanje G, Wilson KS, et al
    Alcohol use and viral suppression in HIV-positive Kenyan female sex workers on antiretroviral therapy.
    PLoS One. 2020;15:e0242817.
    >> Share

  191. TAVANASEFAT H, Li F, Koyano K, Gourtani BK, et al
    Molecular consequences of fetal alcohol exposure on amniotic exosomal miRNAs with functional implications for stem cell potency and differentiation.
    PLoS One. 2020;15:e0242276.
    >> Share

  192. KAN CK, Ragan EJ, Sarkar S, Knudsen S, et al
    Alcohol use and tuberculosis clinical presentation at the time of diagnosis in Puducherry and Tamil Nadu, India.
    PLoS One. 2020;15:e0240595.
    >> Share

  193. SEGHER K, Huys L, Desmet T, Steen E, et al
    Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.
    PLoS One. 2020;15:e0243222.
    >> Share

  194. BITEW MS, Zewde MF, Wubetu M, Alemu AA, et al
    Consumption of alcohol and binge drinking among pregnant women in Addis Ababa, Ethiopia: Prevalence and determinant factors.
    PLoS One. 2020;15:e0243784.
    >> Share

  195. IGLESIAS K, Lannoy S, Sporkert F, Daeppen JB, et al
    Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men.
    PLoS One. 2020;15:e0244336.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016